PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Consumption of Vaccinium spp. is associated with antioxidant, antimicrobial, anti-inflammatory, and protective effects against diabetes, obesity, cancer, neurodegenerative diseases, and cardiovascular disorders [PMID:36838522].
Animal and in vitro studies indicate that huckleberry (specifically bilberry/Vaccinium myrtillus L.) has the potential to ameliorate T2D and its cardio-metabolic outcomes, though appropriate clinical trials are needed [PMID:27748191].
Evidence summary
PubMed sources
- 1.PMID: 41378279 (2025) — Compositional analysis and characterization of black huckleberry and soapberry: Two culturally significant berries for Indigenous communities of the Pacific Northwest. · Food chemistry: X
- 2.PMID: 39504327 (2024) — Effects of bear endozoochory on germination and dispersal of huckleberry in the Canadian Rocky Mountains. · PloS one
- 3.PMID: 41560762 (2026) — Huckleberry Habitat and Its Influence on Two Small Populations of Grizzly Bears (Ursus arctos). · Ecology and evolution
- 4.PMID: 34340566 (2022) — Occurrence of Mummy Berry Associated with Huckleberry (Vaccinium membranaceum) Caused by Monilinia spp. in Oregon. · Plant disease
- 5.PMID: 36838522 (2023)